Ron Cohen
2014
Compensation breakdown
Non-Equity Incentive Plan | $651,600 |
---|---|
Option Awards | $1,939,685 |
Salary | $745,833 |
Stock Awards | $700,413 |
Other | $7,650 |
Total | $4,045,181 |
Cohen received $1.9M in option awards, accounting for 48% of the total pay in 2014.
Cohen also received $651.6K in non-equity incentive plan, $745.8K in salary, $700.4K in stock awards and $7.7K in other compensation.
Rankings
In 2014, Ron Cohen's compensation ranked 2,097th out of 13,032 executives tracked by ExecPay. In other words, Cohen earned more than 83.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,097 | 84th |
Manufacturing | 744 | 85th |
Chemicals And Allied Products | 236 | 86th |
Drugs | 183 | 87th |
Biological Products, Except Diagnostic Substances | 28 | 88th |
Cohen's colleagues
We found six more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2014.
2014
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2014
Jane Wasman
Acorda Therapeutics
General Counsel
2014
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2014
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2014
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
2014
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
News
April 27, 2023
April 28, 2022
April 23, 2021
April 28, 2020
April 26, 2019